Form 8-K - Current report:
SEC Accession No. 0000950170-24-094341
Filing Date
2024-08-09
Accepted
2024-08-09 07:10:28
Documents
13
Period of Report
2024-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prok-20240809.htm   iXBRL 8-K 39860
2 EX-99.1 prok-ex99_1.htm EX-99.1 270547
3 GRAPHIC img22993735_0.jpg GRAPHIC 13089
  Complete submission text file 0000950170-24-094341.txt   461377

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prok-20240809.xsd EX-101.SCH 25827
15 EXTRACTED XBRL INSTANCE DOCUMENT prok-20240809_htm.xml XML 4900
Mailing Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103
Business Address 2000 FRONTIS PLAZA BLVD. SUITE 250 WINSTON-SALEM NC 27103 336-999-7028
PROKIDNEY CORP. (Filer) CIK: 0001850270 (see all company filings)

EIN.: 981586514 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40560 | Film No.: 241190391
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)